Long COVID in Cancer
Olivia Fankuchen(Cornell University), Manish A. Shah(NewYork–Presbyterian Hospital), Laura C. Pinheiro(Cornell University), Mangala Rajan(Cornell University), Manuel Hidalgo(Hospital Universitario de Fuenlabrada), Samuel Yamshon(Cornell University), Brandon Swed(Cornell University), Jennifer D. Lau(Cornell University), Peter Martin(Northwestern University)
Cited by 12
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k